Department of Internal Medicine, Kangwon National University Hospital, Kangwon National University School of Medicine, 156, Baengnyeong-Ro, Chuncheon-Si, Chuncheon, Gangwon-Do, 24289, Republic of Korea.
Biomedical Research Institute, Kangwon National University Hospital, Chuncheon, Gangwon-Do, South Korea.
Sci Rep. 2024 Sep 4;14(1):20651. doi: 10.1038/s41598-024-71438-8.
Severe fever with thrombocytopenia syndrome (SFTS) is a tick-borne illness with a notable morality risk that is becoming increasingly prevalent in East Asia (14-36%). Increasing evidence indicates a more direct role of the SFTS virus in renal impairment. However, few studies have explored the risk factors for and clinical outcomes of AKI in patients with SFTS. Therefore, in this study, we aimed to investigate risk factors and outcomes associated with AKI in patients with SFTS. In this retrospective cohort study, we included the data of 53 patients who were diagnosed with SFTS virus infection at Kangwon National University Hospital between 2016 and 2020. We incorporated laboratory data and medical information including comorbidities, complications, and mortality. Baseline characteristics, clinical features, laboratory parameters, and mortality rates of the non-AKI and AKI groups were compared. Patient survival of non-AKI and AKI groups were compared using the Kaplan-Meier method. To identify the population with poor prognosis, Cox regression analysis was used to identify the independent risk factors for in-hospital mortality in patients with SFTS. Of the 53 individuals, 29 (54.7%) were male, with an average age of 66.5 years. Nine patients (15.1%) died of SFTS. Twenty-seven (50.9%) patients exhibited AKI; the average time interval from fever onset to AKI occurrence was 3.6 days. Notably, 24 (88.9%) patients developed AKI within the first week of fever onset. Patients in the AKI group exhibited a significantly higher prevalence of diabetes and were older than those in the non-AKI group. The mortality rate was notably higher (29.6%) in the AKI group than in the non-AKI group (3.8%). Within the AKI cohort, advanced stages (stages 2 and 3) showed a 50% mortality rate, which was significantly higher than the 17.6% mortality rate in patients with stage 1 AKI. Additionally, Kaplan-Meier curves revealed lower survival rates among patients with AKI than among those without AKI (P = 0.017). Cox regression analysis identified leukopenia and elevated serum creatinine levels as significant risk factors for mortality. AKI is a common complication associated with SFTS. Moreover, the mortality rate was significantly higher in the patients who developed AKI than in those who did not. Our findings underscore the pivotal role of AKI as a prognostic marker of disease severity in patients with SFTS.
严重发热伴血小板减少综合征(SFTS)是一种具有显著死亡率风险的蜱传疾病,在东亚地区越来越普遍(14-36%)。越来越多的证据表明 SFTS 病毒在肾功能损害中发挥更直接的作用。然而,很少有研究探讨 SFTS 患者急性肾损伤(AKI)的危险因素和临床结局。因此,在这项研究中,我们旨在探讨 SFTS 患者 AKI 的相关危险因素和结局。在这项回顾性队列研究中,我们纳入了 2016 年至 2020 年在江原国立大学医院诊断为 SFTS 病毒感染的 53 名患者的数据。我们纳入了实验室数据和包括合并症、并发症和死亡率在内的医疗信息。比较非 AKI 组和 AKI 组的基线特征、临床特征、实验室参数和死亡率。使用 Kaplan-Meier 法比较非 AKI 组和 AKI 组患者的生存情况。为了确定预后不良的人群,我们使用 Cox 回归分析确定 SFTS 患者住院死亡率的独立危险因素。在 53 名患者中,29 名(54.7%)为男性,平均年龄为 66.5 岁。9 名(15.1%)患者因 SFTS 死亡。27 名(50.9%)患者出现 AKI;从发热到 AKI 发生的平均时间间隔为 3.6 天。值得注意的是,24 名(88.9%)患者在发热发病的第一周内发生 AKI。AKI 组患者的糖尿病患病率明显较高,且年龄大于非 AKI 组。AKI 组的死亡率明显高于非 AKI 组(29.6%比 3.8%)。在 AKI 组中,晚期(第 2 期和第 3 期)AKI 的死亡率为 50%,明显高于第 1 期 AKI 患者的 17.6%。此外,Kaplan-Meier 曲线显示 AKI 患者的生存率低于非 AKI 患者(P=0.017)。Cox 回归分析发现白细胞减少和血清肌酐水平升高是死亡的显著危险因素。AKI 是 SFTS 的常见并发症。此外,发生 AKI 的患者死亡率明显高于未发生 AKI 的患者。我们的研究结果强调了 AKI 作为 SFTS 患者疾病严重程度的预后标志物的重要作用。